With 0.5 million shares changed hands, the volume of the stock remained heavier than its average volume of 89700.0 shares. During the session, the Shell Companies company that operates in wider Financial sector, reached to the highest price of $10.35 whereas the lowest price it dropped to was $8.7309. The 52-week range on BBOT shows that it touched its highest point at $11.59 and its lowest point at $8.50 during that stretch. Beta for the stock currently stands at -0.16.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of BBOT was down-trending over the past week, with a drop of -1.01%, but this was down by -8.63% over a month. Three-month performance dropped to -9.77% while six-month performance fell -10.92%. The stock lost -6.76% in the past year, while it has lost -5.87% so far this year.
Float and Shares Shorts:
At present, 18.91 million BBOT shares are outstanding with a float of 17.21 million shares on hand for trading. In addition to Dr. Pedro J. Beltran M.D., Ph.D. as the firm’s Chief Scientific Officer, Dr. Yong Ben M.B.A., M.D. serves as its Chief Medical & Development Officer.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. The EBITDA in the recently reported quarter was -$23083000.0 and diluted EPS was -$0.315135.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Based on analyst estimates, the high estimate for the next quarter is $0 and the low estimate is $0. The average estimate for the next quarter is thus $0.
